Trial Profile
Paroxetine Versus Bupropion for Suicide Ideators or Attempters With Major Depressive Disorder.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2018
Price :
$35
*
At a glance
- Drugs Bupropion (Primary) ; Paroxetine (Primary)
- Indications Major depressive disorder; Suicidal ideation
- Focus Therapeutic Use
- 23 Jan 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 08 Feb 2012 Planned number of patients changed from 100 to 125.
- 03 Feb 2012 Planned end date changed from 1 Jan 2010 to 1 Jan 2013 as reported by ClinicalTrials.gov.